Laurence Ede
Director/Board Member chez Ubiquigent Ltd.
Profil
Laurence Ede is currently a Director at Ubiquigent Ltd., a Non-Executive Director at Rosa Biotech Ltd., and a Director at Manor Road Lettings Ltd.
Previously, he was the Managing Director & Co-Owner of Tocris Bioscience from 2005 to 2013 and an Independent Non-Executive Director at DeepMatter Group Plc from 2017 to 2023.
Ede holds an MBA from the University of Bath and an undergraduate degree from the University of Reading.
Postes actifs de Laurence Ede
| Sociétés | Poste | Début |
|---|---|---|
Ubiquigent Ltd.
 Ubiquigent Ltd. Miscellaneous Commercial ServicesCommercial Services Ubiquigent Ltd. develops reagents, kits, drug discovery assay development and compound profiling services to the academic and commercial life science research community worldwide. It focus; namely the ubiquitin, ubiquitin-like and integrated signalling systems. The company has established its scientific and business credentials with both academic researchers undertaking fundamental scientific discovery as well as with pharmaceutical and biotechnology company scientists undertaking ubiquitin system-focused drug discovery. Ubiquigent was founded by Jason Brown in 2009 and is headquartered in Dundee, the United Kingdom. | Director/Board Member | 01/08/2015 |
Rosa Biotech Ltd.
 Rosa Biotech Ltd. Packaged SoftwareTechnology Services Rosa Biotech Ltd. is a British company that is redefining biosensing. The company is based in Bristol, UK. The company is focused on addressing intractable challenges in early disease diagnosis and industrial biotechnology. The company was founded in 2019. Mark Street-Docherty has been the CEO of the company since 2022. | Director/Board Member | 23/08/2019 |
| Manor Road Lettings Ltd. | Director/Board Member | - |
Anciens postes connus de Laurence Ede
| Sociétés | Poste | Fin |
|---|---|---|
| DEEPMATTER GROUP PLC | Director/Board Member | 02/05/2023 |
Tocris Bioscience
 Tocris Bioscience Chemicals: SpecialtyProcess Industries Part of Tocris Bioscience Management, Tocris Bioscience supplies all types of chemicals. The private company is based in Bristol, UK. Tocris Bioscience was acquired by Tocris Bioscience Management on January 11, 2007 for $39.86 million. | Corporate Officer/Principal | 01/07/2013 |
Formation de Laurence Ede
| University of Bath | Masters Business Admin |
| The University of Reading | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Tocris Bioscience
Tocris Bioscience Chemicals: SpecialtyProcess Industries Part of Tocris Bioscience Management, Tocris Bioscience supplies all types of chemicals. The private company is based in Bristol, UK. Tocris Bioscience was acquired by Tocris Bioscience Management on January 11, 2007 for $39.86 million. | Process Industries |
DeepMatter Group Plc
 DeepMatter Group Plc Packaged SoftwareTechnology Services DeepMatter Group Plc is engaged in the development of a number of projects targeting new chemicals, materials, formulations, and pharmaceuticals in commercial areas. It operates through the following segments: DeepMatter and InfoChem. The DeepMatter segment owns, develops and is in the early stage of exploiting intellectual property, software, hardware and data analysis capabilities combined as a visionary, disruptive platform called DigitalGlassware, enabling step changes in productivity and discovery for scientists in the pharma and life science sectors. The InfoChem segment develops and commercialises cheminformatics software to handle, store and retrieve chemical structures and reactions for application in pharma, life sciences, and scientific publications. The company was founded by Jon-Paul Griffiths and Mark G. Moloney on June 13, 2006 and is headquartered in Glasgow, the United Kingdom. | Technology Services |
Rosa Biotech Ltd.
Rosa Biotech Ltd. Packaged SoftwareTechnology Services Rosa Biotech Ltd. is a British company that is redefining biosensing. The company is based in Bristol, UK. The company is focused on addressing intractable challenges in early disease diagnosis and industrial biotechnology. The company was founded in 2019. Mark Street-Docherty has been the CEO of the company since 2022. | Technology Services |
| Manor Road Lettings Ltd. | |
Ubiquigent Ltd.
Ubiquigent Ltd. Miscellaneous Commercial ServicesCommercial Services Ubiquigent Ltd. develops reagents, kits, drug discovery assay development and compound profiling services to the academic and commercial life science research community worldwide. It focus; namely the ubiquitin, ubiquitin-like and integrated signalling systems. The company has established its scientific and business credentials with both academic researchers undertaking fundamental scientific discovery as well as with pharmaceutical and biotechnology company scientists undertaking ubiquitin system-focused drug discovery. Ubiquigent was founded by Jason Brown in 2009 and is headquartered in Dundee, the United Kingdom. | Commercial Services |
